Synapse - Eileen O'Reilly

Results (803)

Comprehensive molecular characterization of gallbladder carcinoma and potential targets for intervention

Journal Article

Giraldo, N. A.; Drill, E.; Satravada, B. A.; El Dika, I.; Brannon, A. R.; Dermawan, J.; Mohanty, A.; Ozcan, K.; Chakravarty, D.; Benayed, R.; more...
Clinical Cancer Research (2022)

Fulltext@MSK | Save

Erweiterte gesamtüberlebensergebnisse aus der POLO-studie zur aktiven erhaltungstherapie mit olaparib bei patienten mit metastasiertem bauchspeicheldrüsenkrebs und einer keimbahn-BRCA-mutation

Meeting Abstract

Arnold, D.; Golan, T.; Hammel, P.; Reni, M.; Van Cutsem, E.; Macarulla, T.; Hall, M. J.; Park, J. O.; Hochhauser, D.; Oh, D. Y.; more...
Oncology Research and Treatment (2022)

Fulltext@MSK | Save

Timing of onset of systemic treatment in asymptomatic patients with metastatic pancreatic cancer: An international expert survey and case-vignette study

Meeting Abstract

Augustinus, S.; Van Laarhoven, H. W. M.; Cirkel, G. A.; de Groot, J. W.; Koerkamp, B. G.; Macarulla, T.; Melisi, D.; O'Reilly, E. M.; van Santvoort, H.; Mackay, T.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Improving understanding of pancreatic cancer among patients using an animated patient's guide to benefit informed decisions and health outcomes

Meeting Abstract

Munigala, S.; O'Reilly, E. M.; Bakelman, D. E.; Holt, J.; Ko, A. H.; Searle, N.; Gelrud, A.
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Circulating KRAS variant-specific shedding and association with survival in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) receiving chemoimmunotherapy

Meeting Abstract

Till, J. E.; McDaniel, L.; Pfeiffer, S. M.; Maurer, D. M.; Yu, J.; Spencer, C.; Lyman, J. P.; Cabanski, C. R.; Da Silva, D. M.; Abbott, C.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Efficacy and safety of zenocutuzumab, a HER2 x HER3 bispecific antibody, across advanced NRG1 fusion (NRG1+) cancers

Meeting Abstract

Schram, A. M.; Goto, K.; Kim, D. W.; Martin-Romano, P.; Ou, S. H. I.; O'Kane, G. M.; O'Reilly, E. M.; Umemoto, K.; Duruisseaux, M.; Neuzillet, C.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

First-in-human phase 1 trial of ELI-002 immunotherapy as treatment for subjects with Kirsten rat sarcoma (KRAS)-mutated pancreatic ductal adenocarcinoma and other solid tumors

Meeting Abstract

Pant, S.; Furqan, M.; Abdul-Karim, R. M.; Chung, V.; Devoe, C. E.; Johnson, M. L.; Leal, A. D.; Park, H.; Wainberg, Z. A.; Welkowsky, E.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Zolbetuximab plus gemcitabine and nab-paclitaxel (GN) in first-line treatment of claudin 18.2-positive metastatic pancreatic cancer (mPC): Phase 2, open-label, randomized study

Meeting Abstract

Park, W.; O'Reilly, E. M.; Furuse, J.; Li, C. P.; Oh, D. Y.; Garcia-Carbonero, R.; Roth, G.; Lee, H. J.; Kunieda, F.
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Immunogenomic characterization of biliary tract cancers: Biomarker enrichment for benefit to immune checkpoint blockade

Meeting Abstract

Park, W.; Keane, F.; Bandlamudi, C.; Donoghue, M.; de Lara, P. T.; Harding, J. J.; Khalil, D.; McKinnell, Z.; Sterpi, M.; Cao, W.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Distinct biosignatures associate with survival after chemoimmunotherapy in a randomized, three-arm phase II study in patients with metastatic pancreatic cancer

Meeting Abstract

Padrón, L. J.; Maurer, D. M.; O'Hara, M. H.; O'Reilly, E. M.; Wolff, R. A.; Wainberg, Z. A.; Ko, A. H.; Fisher, G. A.; Rahma, O. E.; Lyman, J. P.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save